High density lipoproteins and kidney function: the friend turned foe?
作者信息
Badimon Lina, Vilahur Gemma, Cubedo Judit
机构信息
Cardiovascular Research Center (CSIC-ICCC) and Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain;; Cardiovascular Research Chair UAB, Barcelona, Spain.
Cardiovascular Research Center (CSIC-ICCC) and Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
出版信息
J Thorac Dis. 2016 Nov;8(11):2978-2981. doi: 10.21037/jtd.2016.11.66.
Abstract
摘要
相似文献
1
High density lipoproteins and kidney function: the friend turned foe?高密度脂蛋白与肾功能：朋友会变成敌人吗？
J Thorac Dis. 2016 Nov;8(11):2978-2981. doi: 10.21037/jtd.2016.11.66.
2
Hepatic lipase: friend or foe and under what circumstances?肝脂肪酶：是友是敌，取决于何种情形？
Curr Atheroscler Rep. 2004 Sep;6(5):343-7. doi: 10.1007/s11883-004-0044-3.
3
Friend turned foe: E-cadherin perversely protects micrometastases.友变敌：E-钙黏蛋白反常地保护微转移灶。
Transl Androl Urol. 2017 Apr;6(2):338-340. doi: 10.21037/tau.2017.03.25.
4
[Microbial "friend-foe" identification in human intestine microsymbiocenosis].[人体肠道微共生群落中微生物“敌友”识别]
Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec(6):46-51.
5
FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.友敌：手术和创伤患者再次插管的风险因素的前瞻性评估。
Am J Surg. 2018 Dec;216(6):1056-1062. doi: 10.1016/j.amjsurg.2018.07.004. Epub 2018 Jul 10.
6
Extracellular hemoglobin: the case of a friend turned foe.细胞外血红蛋白：从朋友到敌人的转变
Front Physiol. 2015 Apr 20;6:96. doi: 10.3389/fphys.2015.00096. eCollection 2015.
7
Cholesteryl ester transfer protein: friend or foe?胆固醇酯转运蛋白：益友还是劲敌？
J Clin Invest. 1996 Jun 15;97(12):2687-8. doi: 10.1172/JCI118719.
8
Chromium: friend or foe?铬：是友还是敌？
Arch Fam Med. 1999 Sep-Oct;8(5):386-90. doi: 10.1001/archfami.8.5.386.
9
HDL's protein cargo: friend or foe in cardioprotection?高密度脂蛋白的蛋白质成分：心脏保护中的朋友还是敌人？
Circulation. 2013 Feb 26;127(8):868-9. doi: 10.1161/CIRCULATIONAHA.112.000889.
10
Noradrenaline and the kidney: foe, friend, or both?去甲肾上腺素与肾脏：敌人、朋友，还是兼而有之？
Intensive Care Med. 2005 Nov;31(11):1476-8. doi: 10.1007/s00134-005-2740-z. Epub 2005 Aug 9.
引用本文的文献
1
Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study.植物甾醇和ω-3补充剂对代谢和炎症途径发挥新的调节作用：一项蛋白质组学研究
Nutrients. 2017 Jun 13;9(6):599. doi: 10.3390/nu9060599.
本文引用的文献
1
2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals.2013年美国心脏病学会/美国心脏协会胆固醇指南及其对《健康人民2020》心血管疾病预防目标的影响。
J Am Heart Assoc. 2016 Aug 19;5(8):e003558. doi: 10.1161/JAHA.116.003558.
2
High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.高密度脂蛋白胆固醇与美国退伍军人全因死亡风险
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1784-1793. doi: 10.2215/CJN.00730116. Epub 2016 Aug 11.
3
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.家族性高胆固醇血症患者高密度脂蛋白中的载脂蛋白L1水平与心血管事件表现
J Lipid Res. 2016 Jun;57(6):1059-73. doi: 10.1194/jlr.P061598. Epub 2016 Apr 25.
4
Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population.肾功能作为澳大利亚人群高密度脂蛋白和甘油三酯浓度的一个决定因素。
J Clin Med. 2016 Mar 8;5(3):35. doi: 10.3390/jcm5030035.
5
Hypercholesterolemia Abolishes High-Density Lipoprotein-Related Cardioprotective Effects in the Setting of Myocardial Infarction.
J Am Coll Cardiol. 2015 Dec 1;66(21):2469-2470. doi: 10.1016/j.jacc.2015.08.901.
6
High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.慢性肾脏病患者的高密度脂蛋白亚组分及其氧化亚组分颗粒
J Atheroscler Thromb. 2016;23(1):81-94. doi: 10.5551/jat.30015. Epub 2015 Aug 18.
7
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.慢性肾脏病中的残余心血管风险：高密度脂蛋白的作用
Arch Med Res. 2015 Jul;46(5):379-91. doi: 10.1016/j.arcmed.2015.05.009. Epub 2015 May 23.
8
HDL particles--more complex than we thought.高密度脂蛋白颗粒——比我们想象的更复杂。
Thromb Haemost. 2014 Nov;112(5):857. doi: 10.1160/TH14-10-0831. Epub 2014 Oct 9.
9
Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.获得性卵磷脂胆固醇酰基转移酶缺乏症是慢性肾脏病患者降低血浆高密度脂蛋白水平的主要因素。
J Intern Med. 2015 May;277(5):552-61. doi: 10.1111/joim.12290. Epub 2014 Aug 1.
10
HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.高密度脂蛋白胆固醇与肾功能不全患者的较低死亡率无关。
J Am Soc Nephrol. 2014 May;25(5):1073-82. doi: 10.1681/ASN.2013050482. Epub 2014 Mar 7.
Zotero 插件